120925-79-3

Upstream product

• 109-65-9 1-bromo-butane 
• 113826-06-5 (R)-glycidyl tosylate 
• 98-59-9 p-toluenesulfonyl chloride 
• 3710-31-4 1,2-heptanediol 
• 592-76-7 1-Heptene 
• 78843-64-8 (2R)-heptane-1,2-diol 

Downstream Products

• 110549-07-0 (R)-1,2-epoxyheptane 
• 1554321-17-3 (R)-non-1-yn-4-ol 
• 1554321-21-9 (3R,7R)-methyl 3-hydroxy-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-ynoate 
• 1554321-23-1 (3S,7R,Z)-methyl 3-hydroxy-7-(4-methoxybenzyloxy)-2,2-dimethyl-4-(triphenylstannyl)dodec-4-enoate 
• 1554321-25-3 (3S,7R,Z)-methyl 3-hydroxy-4-iodo-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-enoate 
• 1554321-27-5 (3S,7R,Z)-methyl 3-(tert-butyldimethylsilyloxy)-4-iodo-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-enoate 
• 1554321-29-7 (3R,7R,E)-methyl 3-(tert-butyldimethylsilyloxy)-7-(4-methoxybenzyloxy)-2,2,4-trimethyldodec-4-enoate 
• 1554321-31-1 (3R,7R)-methyl 3-(tert-butyldimethylsilyloxy)-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-ynoate 
• 1554321-33-3 (3R,7R)-3-(tert-butyldimethylsilyloxy)-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-yn-1-ol 
• 1554321-35-5 (3R,7R)-3-(tert-butyldimethylsilyloxy)-7-(4-methoxybenzyloxy)-2,2-dimethyldodec-4-ynal 
• 1554321-42-4 (4S,5S,7R,11R)-7-(tert-butyldimethylsilyloxy)-5-hydroxy-11-(4-methoxybenzyloxy)-4,6,6-trimethylhexadeca-2,8-diynyl pivalate 
• 1554321-43-5 (4S,5R,7R,11R)-7-(tert-butyldimethylsilyloxy)-5-hydroxy-11-(4-methoxybenzyloxy)-4,6,6-trimethylhexadeca-2,8-diynyl pivalate 
• 1554321-45-7 (4S,5S,7R,11R)-5,7-dihydroxy-11-(4-methoxybenzyloxy)-4,6,6-trimethylhexadeca-2,8-diynyl pivalate 
• 1554321-47-9 (S)-4-((4S,6R)-6-((R)-4-(4-methoxybenzyloxy)non-1-ynyl)-2,2,5,5-tetramethyl-1,3-dioxan-4-yl)pent-2-ynyl pivalate 

Relevant academic research and scientific papers

Synthesis of the C(7)-C(22) Sector of (+)-Acutiphycin via O-directed double free radical alkyne hydrostannation with Ph3SnH/Et3B, double I-Sn exchange, and double stille coupling

Herein a new double O-directed free radical hydrostannation reaction is reported on the structurally complex dialkyldiyne 11. Through our use of a conformation-restraining acetal to help prevent stereocenter-compromising 1,5-H-atom abstraction reactions b

Fluorine-containing optically active compound and liquid crystal composition containing the same

A fluorine-containing optically active compound represented by formula (I): STR1 wherein R1 represents a straight chain alkyl or alkoxy group having from 6 to 14 carbon atoms or a 4-alkylphenyl or 4-alkoxyphenyl group having from 8 to 12 carbon

Method for producing optically active glycol derivatives

A method for producing optically active glycol derivatives by biochemical resolution which comprises contacting a racemic ester of the general formula 1 STR1 (wherein R1 is an aliphatic hydrocarbon group of 1 to 16 carbon atoms, R2 i

7-Oxabicycloheptane substituted amino prostaglandin analogs and their use in inhibiting platelet aggregation and bronchoconstriction

7-Oxabicycloheptane substituted amino prostaglandin analogs are provided having the structural formula STR1 and including all stereoisomers thereof. The compounds are cardiovascular agents useful, for example, in the treatment of thrombolytic disease.